{"transactions":[{"id":3074130,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":147552,"kind":"person","name":"HERSCHA LYNETTE","position":1,"cik":"0001708198","reported_name":"HERSCHA LYNETTE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Restricted Stock Units","published_at":"2020-07-29T17:28:37.000Z","date":"2020-07-27","kind":"exercise","acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 27, 2020, the reporting person was granted 32,000 restricted stock units, vesting in two equal installments. Fifty percent vest six months after the grant date with the remaining fifty percent vesting on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 27, 2020, the reporting person was granted 32,000 restricted stock units, vesting in two equal installments. Fifty percent vest six months after the grant date with the remaining fifty percent vesting on the first anniversary of the grant date."}],"balance_after":16000,"derivative":{"underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-20-043952","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708198/000120919120043952/doc4.xml","form_type":"4"}},{"id":3074129,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":147552,"kind":"person","name":"HERSCHA LYNETTE","position":1,"cik":"0001708198","reported_name":"HERSCHA LYNETTE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2020-07-29T17:28:37.000Z","date":"2020-07-28","kind":"sale","acquired":false,"shares":5141,"price":2.4193,"value":12437.6213,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units."}],"balance_after":160859,"source":{"system":"sec-edgar","filing":"0001209191-20-043952","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708198/000120919120043952/doc4.xml","form_type":"4"}},{"id":3074128,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":147552,"kind":"person","name":"HERSCHA LYNETTE","position":1,"cik":"0001708198","reported_name":"HERSCHA LYNETTE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2020-07-29T17:28:37.000Z","date":"2020-07-27","kind":"exercise","acquired":true,"shares":16000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":166000,"source":{"system":"sec-edgar","filing":"0001209191-20-043952","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708198/000120919120043952/doc4.xml","form_type":"4"}},{"id":3105633,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":147552,"kind":"person","name":"HERSCHA LYNETTE","position":1,"cik":"0001708198","reported_name":"HERSCHA LYNETTE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2020-06-18T18:01:15.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction is a grant of restricted stock units representing 75,000 shares of common stock. This grant will vest in two equal installments with the first fifty percent vesting on March 11, 2021 and the second fifty percent on March 11, 2022."}],"balance_after":150000,"source":{"system":"sec-edgar","filing":"0001209191-20-037688","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708198/000120919120037688/doc4.xml","form_type":"4"}},{"id":3211284,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":147552,"kind":"person","name":"HERSCHA LYNETTE","position":1,"cik":"0001708198","reported_name":"HERSCHA LYNETTE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2020-03-13T16:36:09.000Z","date":"2020-03-11","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction is a grant of restricted stock units representing 75,000 shares of common stock.  This grant will vest evenly over 2 years with the first fifty percent vesting on the first anniversary of the grant date and the second fifty percent vesting on the second anniversary of the grant date."}],"balance_after":75000,"source":{"system":"sec-edgar","filing":"0001209191-20-018883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708198/000120919120018883/doc4.xml","form_type":"4"}},{"id":3298866,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":147552,"kind":"person","name":"HERSCHA LYNETTE","position":1,"cik":"0001708198","reported_name":"HERSCHA LYNETTE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-01-29T17:31:56.000Z","date":"2020-01-27","kind":"grant","acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest in 2 installments. Fifty percent will vest six months after the grant date with the remaining fifty percent vesting on the first anniversary of the grant date and will vest automatically as to 100% of the unvested portion of such restricted stock unit grant upon specified change in control events and the termination of the Reporting Person's employment under specified circumstances."}],"balance_after":32000,"derivative":{"exercise_price":0,"expiration_date":"2030-01-27","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001209191-20-005408","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708198/000120919120005408/doc4.xml","form_type":"4"}},{"id":3298865,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":147552,"kind":"person","name":"HERSCHA LYNETTE","position":1,"cik":"0001708198","reported_name":"HERSCHA LYNETTE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-01-29T17:31:56.000Z","date":"2020-01-27","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 27, 2020 and vests in four equal annual installments on the anniversary of the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events and the termination of the Reporting Person's employment under specified circumstances."}],"balance_after":65000,"derivative":{"exercise_price":3.47,"expiration_date":"2030-01-27","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-20-005408","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708198/000120919120005408/doc4.xml","form_type":"4"}},{"id":3642062,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":147552,"kind":"person","name":"HERSCHA LYNETTE","position":1,"cik":"0001708198","reported_name":"HERSCHA LYNETTE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remark"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-21T16:06:24.000Z","date":"2019-02-19","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted February 19, 2019 and vests in four equal annual installments on the anniversary of the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events and the termination of the Reporting Person's employment under specified circumstances."}],"balance_after":50000,"derivative":{"exercise_price":8.2,"expiration_date":"2029-02-19","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-19-004375","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708198/000089924319004375/doc4.xml","form_type":"4"}},{"id":3964051,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":147552,"kind":"person","name":"HERSCHA LYNETTE","position":1,"cik":"0001708198","reported_name":"HERSCHA LYNETTE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2018-04-13T16:50:23.000Z","date":"2018-03-31","kind":"tax_withholding","acquired":false,"shares":3682,"price":22.9,"value":84317.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction represents withholding of shares to satisfy tax withholding obligations upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amendment is being filed to reduce the number of securities beneficially owned by the reporting person by 12,500 shares of common stock due to the failure to achieve certain performance criteria set forth in the restricted stock unit grant agreement with the reporting person dated July 6, 2017."}],"balance_after":33818,"source":{"system":"sec-edgar","filing":"0001209191-18-024843","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708198/000120919118024843/doc4a.xml","form_type":"4/A","original_submission_date":"2018-04-03"}},{"id":3973483,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":147552,"kind":"person","name":"HERSCHA LYNETTE","position":1,"cik":"0001708198","reported_name":"HERSCHA LYNETTE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2018-04-03T16:18:19.000Z","date":"2018-03-31","kind":"tax_withholding","acquired":false,"shares":3682,"price":22.9,"value":84317.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction represents withholding of shares to satisfy tax withholding obligations upon the vesting of restricted stock units."}],"balance_after":46318,"source":{"system":"sec-edgar","filing":"0001209191-18-022920","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708198/000120919118022920/doc4.xml","form_type":"4"}},{"id":4104351,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":147552,"kind":"person","name":"HERSCHA LYNETTE","position":1,"cik":"0001708198","reported_name":"HERSCHA LYNETTE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-01-08T18:34:32.000Z","date":"2018-01-04","kind":"grant","acquired":true,"shares":49500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in sixteen equal quarterly installments beginning on April 4, 2018."}],"balance_after":49500,"derivative":{"exercise_price":27.59,"expiration_date":"2028-01-03","underlying":"Common Stock","underlying_shares":49500},"source":{"system":"sec-edgar","filing":"0001209191-18-002787","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708198/000120919118002787/doc4.xml","form_type":"4"}},{"id":4260011,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":147552,"kind":"person","name":"HERSCHA LYNETTE","position":1,"cik":"0001708198","reported_name":"HERSCHA LYNETTE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2017-07-10T07:07:44.000Z","date":"2017-07-06","kind":"grant","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Common Stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"50% of the RSUs granted to Ms. Herscha are eligible to vest on March 31, 2018, subject to the achievement certain performance criteria prior to March 31, 2018, including the closing of the Asset Purchase Agreement with Vertex Pharmaceuticals, Inc. and the institution by the Patent Trial and Appeal Board of a Post Grant Review petition filed by the Issuer against Incyte\nCorporation, and the remaining 50% of the RSUs are time-based awards and will vest on March 31, 2019. The number above represents the maximum number of shares that may be delivered pursuant to the award."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001209191-17-044472","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708198/000120919117044472/doc4.xml","form_type":"4"}},{"id":4277621,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":147552,"kind":"person","name":"HERSCHA LYNETTE","position":1,"cik":"0001708198","reported_name":"HERSCHA LYNETTE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-06-19T07:36:26.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in sixteen equal quarterly installments beginning on September 15, 2017."}],"balance_after":10000,"derivative":{"exercise_price":13.29,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-040711","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708198/000120919117040711/doc4.xml","form_type":"4"}}]}